Viridian Therapeutics, Inc.\DE: Peers

The FY2024 (Dec) proxy of Viridian Therapeutics, Inc.\DE names 22 peer companies for pay. Pay versus performance data of Viridian Therapeutics, Inc.\DE for that year is not on file, so it has no rank.

Pay peer group, FY2024 (Dec) proxy

Anaptysbio
Celldex Therapeutics
Immunovant
Arcus Biosciences
Keros Therapeutics
Kura Oncology
Arcutis Biotherapeutics
Aerovate TherapeuticsNot disclosedNot disclosed
Akero TherapeuticsNot disclosedNot disclosed
Crinetics PharmaceuticalsNot disclosedNot disclosed
Day One BiopharmaceuticalsNot disclosedNot disclosed
KalVista PharmaceuticalsNot disclosedNot disclosed
Kiniksa PharmaceuticalsNot disclosedNot disclosed
Mersana TherapeuticsNot disclosedNot disclosed
Morphic HoldingNot disclosedNot disclosed
Pliant TherapeuticsNot disclosedNot disclosed
ProthenaNot disclosedNot disclosed
Replimune GroupNot disclosedNot disclosed
Sutro BiopharmaNot disclosedNot disclosed
Syndax PharmaceuticalsNot disclosedNot disclosed
Ventyx BiosciencesNot disclosedNot disclosed
Viking TherapeuticsNot disclosedNot disclosed
22 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.